Selection of oocytes using follicular fluid miRNA markers that correlate with pregnancy outcome can provide fertility treatments with high pregnancy rates
Measurement of Two Markers in urine samples enables colorectal cancer risk diagnosis with sensitivity: 94.3%, specificity: 63.4%, AUC=0.870.
Gene copy number profile of extracellular vesicles in body fluid to determine the sensitivity of ovarian cancer to the anticancer drug PARP inhibitors.
Diagnostic biomarkers for stratification of COVID-19 patients and prediction of prognostic severity.
Biomarkers for prediction and diagnosis of interstitial pneumonia, a side effect of cancer treatment with immune checkpoint inhibitors
POI could be diagnosed by detecting autoantibody reacting to POTE proteins expressing in ovarian tissue
Screening test for early stage gastric cancer, esophageal cancer and colorectal cancer patients by measuring urine miRNAs specific to each cancer.
About Bionauts.jp
